Literature DB >> 12388718

Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.

Brian R Lane1, Jianguo Liu, Paul J Bock, Dominique Schols, Michael J Coffey, Robert M Strieter, Peter J Polverini, David M Markovitz.   

Abstract

The development of the complex neoplasm Kaposi's sarcoma is dependent on infection with the Kaposi's sarcoma-associated herpesvirus (KSHV) and appears to be greatly enhanced by cytokines and human immunodeficiency virus type 1 (HIV-1) Tat. Interleukin-8 (IL-8) and growth-regulated oncogene alpha (GRO-alpha) are chemokines involved in chemoattraction, neovascularization, and stimulation of HIV-1 replication. We have previously demonstrated that production of GRO-alpha is stimulated by exposure of monocyte-derived macrophages (MDM) to HIV-1. Here we show that exposure of MDM to HIV-1, viral Tat, or viral gp120 leads to a substantial increase in IL-8 production. We also demonstrate that IL-8 and GRO-alpha are induced by KSHV infection of endothelial cells and are crucial to the angiogenic phenotype developed by KSHV-infected endothelial cells in cell culture and upon implantation into SCID mice. Thus, the three known etiological factors in Kaposi's sarcoma pathogenesis-KSHV, HIV-1 Tat, and cellular growth factors-might be linked, in part, through induction of IL-8 and GRO-alpha.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388718      PMCID: PMC136744          DOI: 10.1128/jvi.76.22.11570-11583.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  97 in total

1.  Chemokines and HIV replication.

Authors:  H Schmidtmayerova; B Sherry; M Bukrinsky
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

3.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Authors:  G Alkhatib; C Combadiere; C C Broder; Y Feng; P E Kennedy; P M Murphy; E A Berger
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

4.  Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus.

Authors:  R Esser; W Glienke; H von Briesen; H Rübsamen-Waigmann; R Andreesen
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

Review 5.  The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery.

Authors:  S A Strathdee; P J Veugelers; P S Moore
Journal:  AIDS       Date:  1996       Impact factor: 4.177

6.  A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

Authors:  B J Doranz; J Rucker; Y Yi; R J Smyth; M Samson; S C Peiper; M Parmentier; R G Collman; R W Doms
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

7.  Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8.

Authors:  M R Capobianchi; C Barresi; P Borghi; S Gessani; L Fantuzzi; F Ameglio; F Belardelli; S Papadia; F Dianzani
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.

Authors:  R Masood; J Cai; T Zheng; D L Smith; Y Naidu; P S Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

9.  Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.

Authors:  E Cornali; C Zietz; R Benelli; W Weninger; L Masiello; G Breier; E Tschachler; A Albini; M Stürzl
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

10.  A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

Authors:  C C Bleul; R C Fuhlbrigge; J M Casasnovas; A Aiuti; T A Springer
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  28 in total

1.  Regulation of Nm23-H1 and cell invasiveness by Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhiqiang Qin; Lu Dai; Bryan Toole; Erle Robertson; Chris Parsons
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Authors:  R N Fichorova; F Zhou; V Ratnam; V Atanassova; S Jiang; N Strick; A R Neurath
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo.

Authors:  David Maussang; Azra Mujić-Delić; Francis J Descamps; Catelijne Stortelers; Peter Vanlandschoot; Marijke Stigter-van Walsum; Henry F Vischer; Maarten van Roy; Maria Vosjan; Maria Gonzalez-Pajuelo; Guus A M S van Dongen; Pascal Merchiers; Philippe van Rompaey; Martine J Smit
Journal:  J Biol Chem       Date:  2013-08-26       Impact factor: 5.157

4.  Increased circulating concentrations of growth-related oncogene (GRO)-alpha in patients with inflammatory bowel disease.

Authors:  Keiichi Mitsuyama; Osamu Tsuruta; Nobuo Tomiyasu; Kosuke Takaki; Asuka Suzuki; Junya Masuda; Hiroshi Yamasaki; Atsushi Toyonaga; Michio Sata
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

5.  Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.

Authors:  Thomas S Uldrick; Kathleen M Wyvill; Pallavi Kumar; Deirdre O'Mahony; Wendy Bernstein; Karen Aleman; Mark N Polizzotto; Seth M Steinberg; Stefania Pittaluga; Vickie Marshall; Denise Whitby; Richard F Little; Robert Yarchoan
Journal:  J Clin Oncol       Date:  2012-03-19       Impact factor: 44.544

6.  Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  Melanie M Brinkmann; Marcel Pietrek; Oliver Dittrich-Breiholz; Michael Kracht; Thomas F Schulz
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

7.  Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.

Authors:  Laurie T Krug; Veronika P Pozharskaya; Yimin Yu; Naoki Inoue; Margaret K Offermann
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  KSHV-induced notch components render endothelial and mural cell characteristics and cell survival.

Authors:  Ren Liu; Xiuqing Li; Anil Tulpule; Yue Zhou; Jeffrey S Scehnet; Shaobing Zhang; Jong-Soo Lee; Preet M Chaudhary; Jae Jung; Parkash S Gill
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

9.  Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cells.

Authors:  Feng-Chun Ye; Fu-Chun Zhou; Stanley Nithianantham; Bala Chandran; Xiao-Lan Yu; Aaron Weinberg; Shou-Jiang Gao
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment.

Authors:  Lars Mueller; Freya A Goumas; Marianne Affeldt; Susanne Sandtner; Ursula M Gehling; Silke Brilloff; Jessica Walter; Nadia Karnatz; Katrin Lamszus; Xavier Rogiers; Dieter C Broering
Journal:  Am J Pathol       Date:  2007-10-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.